Evidence map›Paper›PMID 35634307›Full record

ReviewFrontiers in immunology2022

Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis.

Karim M Aloul, Josefine Eilsø Nielsen, Erwin B Defensor, Jennifer S Lin, John A Fortkort, Mehrdad Shamloo, Jeffrey D Cirillo, Adrian F Gombart, Annelise E Barron

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. β-Amyloid (Aβ) and Human Cathelicidin LL-37: Two Sides of the Same Coin?International journal of molecular sciences · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Post-burn Lung Inflammation Is Associated With Induction of Pulmonary Cathelicidin-related Antimicrobial Peptide and S100a8 in Mice.Journal of burn care & research : official publication of the American Burn Association · 2025
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. The Role and Clinical Significance of Vitamin D in Chronic Obstructive Pulmonary Disease.International journal of chronic obstructive pulmonary disease · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Karim M AloulDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, CA, United States.
Josefine Eilsø NielsenDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, CA, United States.
Erwin B DefensorDepartment of Neurosurgery, School of Medicine, Stanford University, Stanford, CA, United States.
Jennifer S LinDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, CA, United States.
John A FortkortDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, CA, United States.
Mehrdad ShamlooDepartment of Neurosurgery, School of Medicine, Stanford University, Stanford, CA, United States.
Jeffrey D CirilloDepartment of Microbial Pathogenesis and Immunology, Texas A&M College of Medicine, Bryan, TX, United States.
Adrian F GombartDepartment of Biochemistry and Biophysics, Oregon State University, Corvallis, OR, United States.
Annelise E BarronDepartment of Bioengineering, Schools of Medicine and of Engineering, Stanford University, Stanford, CA, United States.
Stanford University · USOregon State University · USTexas A&M Health Science Center · US

Funding

Role of Innate Immune Dysregulation in the Etiology of DementiaDP1AG072438 · NIA · STANFORD UNIVERSITY · PI BARRON, ANNELISE EMILY · 2020 to 2024
$5.2M
NIA NIH HHS DP1 AG072438
6 · The paper itself

Abstract

COVID-19 is characterized by hyperactivation by inflammatory cytokines and recruitment of macrophages, neutrophils, and other immune cells, all hallmarks of a strong inflammatory response that can lead to severe complications and multi-organ damage. Mortality in COVID-19 patients is associated with a high prevalence of neutrophil extracellular trap (NET) formation and microthrombosis that are exacerbated by hyperglycemia, diabetes, and old age. SARS-CoV-2 infection in humans and non-human primates have revealed long-term neurological consequences of COVID-19, possibly concomitant with the formation of Lewy bodies in the brain and invasion of the nervous system

Indexed as

COVID-19AnimalsAntimicrobial Cationic PeptidesAntimicrobial PeptidesCathelicidinsHumansPeptidyl-Dipeptidase ASARS-CoV-2Antimicrobial Cationic PeptidesAntimicrobial PeptidesCathelicidinsPeptidyl-Dipeptidase Aalpha synucleincathelicidinCOVID-19diabetesLL-37NET clearanceneutrophil extracellular trap (NET)SARS-CoV-2

Identifiers

PMID35634307
PMCPMC9134243
OpenAlexW4280527114

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.